Concept:
Ceftriaxone is a broad-spectrum, third-generation cephalosporin commonly utilized at high doses ($100\text{ mg/kg/day}$) in pediatric bacterial meningitis due to its excellent cerebrospinal fluid penetration.
A well-documented adverse effect associated with high-dose or prolonged ceftriaxone therapy is the formation of biliary sludge and pseudolithiasis.
Explanation:
• Ceftriaxone has a dual elimination pathway, with approximately $40\%$ excreted unchanged into the bile where it reaches high concentrations.
• In the gallbladder, ceftriaxone anions bind with divalent calcium ions ($Ca^{2+}$) to form an insoluble, radio-opaque precipitate of calcium-ceftriaxone salt.
• This precipitates clinically as biliary pseudolithiasis (biliary sludging or reversible gallstones), occurring in up to $15$--$40\%$ of children receiving high-dose regimens.
• Affected children can present with symptoms mimicking acute cholecystitis, including right upper quadrant (hypochondrial) pain, vomiting, nausea, and obstructive jaundice.
• Unlike true cholesterol or pigment stones, ceftriaxone-induced pseudolithiasis is completely reversible and spontaneously resolves within several days to weeks after discontinuing the drug.
• Vancomycin and amikacin are nephrotoxic and ototoxic, while meropenem rarely induces biliary sludging.
Final Answer:
Ceftriaxone is the drug responsible for calcium-ceftriaxone biliary precipitation, causing biliary pseudolithiasis, right hypochondrial pain, and jaundice.